Clinical Trials on Exploring Risk Assessment and Recovery From COVID-19 Infection in Hospitalised Patients in New Zealand

Total 3 results

TScan Therapeutics, Inc.

Completed

Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes

Identify the Viral Epitopes of Memory CD8 T Cells From Individuals That Have Recovered From SARS-CoV-2 Infection | Determine Which SARS-CoV-2 Proteins Are Frequently Recognized by T Cells in Patients With Varying HLA Types

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of Risk Factors for the COVID-19 Virus Infection

COVID-19 Infections in Cancer Patients

United States
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia (CAN-COVID)

Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia

Spain, United States, United Kingdom, Russian Federation, Italy, France

3

Subscribe